Molecular Characterization of 9p21 Deletions Shows a Minimal Common Deleted Region Removing CDKN2A Exon 1 and CDKN2B Exon 2 in Diffuse Large B-Cell Lymphomas

被引:8
|
作者
Guney, Suzan [1 ,2 ]
Bertrand, Philippe [1 ,2 ]
Jardin, Fabrice [1 ,2 ,3 ]
Ruminy, Philippe [1 ,2 ]
Kerckaert, Jean Pierre [4 ]
Tilly, Herve [1 ,2 ,3 ]
Bastard, Christian [1 ,2 ]
机构
[1] Ctr Henri Becquerel, Lab Genet Oncol, F-76038 Rouen, France
[2] IFRMP23, INSERM, U918, Grp Etud Proliferat Lymphoides, Rouen, France
[3] Ctr Henri Becquerel, Dept Hematol, F-76038 Rouen, France
[4] Inst Rech Canc Lille, INSERM, U837, Lille, France
来源
GENES CHROMOSOMES & CANCER | 2011年 / 50卷 / 09期
关键词
HYPERMETHYLATION-ASSOCIATED INACTIVATION; T-CELL; HISTOLOGIC TRANSFORMATION; HOMOZYGOUS DELETIONS; V(D)J RECOMBINATION; MTS1 P16(INK4A); POOR-PROGNOSIS; GENES P15; EXPRESSION; FREQUENT;
D O I
10.1002/gcc.20893
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Diffuse large B cell lymphoma represent the most frequent subtype of non Hodgkin's lymphoma, accounting for 30-40% of cases. Several studies have shown that CDKN2A and CDKN2B deletions are frequent in these lymphomas. These genes encode the P14ARF, CDKN2A, and CDKN2B proteins which play a key role in the control of the G1/S transition of the cell cycle. Using array CGH and a quantitative multiplex PCR method, we have previously identified such deletions in 36% of cases at diagnosis. Using a walking strategy to approach the breakpoints of these deletions we could identify the breakpoints junction of thirteen deletions in 11 patients and of two unbalanced translocation leading to a loss of these genes. A minimal common deleted region of 22.4 kb containing exon 1 beta of CDKN2A encoding P14ARF and exon 2 of CDKN2B encoding CDKN2B was present in all cases but one. Analysis by quantitative RT PCR showed that the expression level of these genes was decreased in these patients as compared with non deleted cases and that this level was correlated with the deletion status of P14ARF, CDKN2A, and CDKN2B. Analysis of the breakpoint sequences showed that some of them were clustered within a few hundred base-pairs suggesting, even if we failed to identify any clear recombination prone sequences, that in these deletions the rearrangement results from non-random mechanisms. (C) 2011 Wiley-Liss, Inc.
引用
收藏
页码:715 / 725
页数:11
相关论文
共 49 条
  • [21] Expression of Chr9p21 genes CDKN2B (p15INK4b), CDKN2A (p16INK4a, p14ARF) and MTAP in human atherosclerotic plaque
    Holdt, Lesca Miriam
    Sass, Kristina
    Gaebel, Gabor
    Bergert, Hendrik
    Thiery, Joachim
    Teupser, Daniel
    ATHEROSCLEROSIS, 2011, 214 (02) : 264 - 270
  • [22] A variant at 9p21.3 functionally implicates CDKN2B in paediatric B-cell precursor acute lymphoblastic leukaemia aetiology
    Eric A. Hungate
    Sapana R. Vora
    Eric R. Gamazon
    Takaya Moriyama
    Timothy Best
    Imge Hulur
    Younghee Lee
    Tiffany-Jane Evans
    Eva Ellinghaus
    Martin Stanulla
    Jéremie Rudant
    Laurent Orsi
    Jacqueline Clavel
    Elizabeth Milne
    Rodney J. Scott
    Ching-Hon Pui
    Nancy J. Cox
    Mignon L. Loh
    Jun J. Yang
    Andrew D. Skol
    Kenan Onel
    Nature Communications, 7
  • [23] A variant at 9p21.3 functionally implicates CDKN2B in paediatric B-cell precursor acute lymphoblastic leukaemia aetiology
    Hungate, Eric A.
    Vora, Sapana R.
    Gamazon, Eric R.
    Moriyama, Takaya
    Best, Timothy
    Hulur, Imge
    Lee, Younghee
    Evans, Tiffany-Jane
    Ellinghaus, Eva
    Stanulla, Martin
    Rudant, Jeremie
    Orsi, Laurent
    Clavel, Jacqueline
    Milne, Elizabeth
    Scott, Rodney J.
    Pui, Ching-Hon
    Cox, Nancy J.
    Loh, Mignon L.
    Yang, Jun J.
    Skol, Andrew D.
    Onel, Kenan
    NATURE COMMUNICATIONS, 2016, 7
  • [24] Frequent allelic losses of 9p21 markers and low incidence of mutations at p16(CDKN2) gene in non-Hodgkin lymphomas of B-cell lineage
    FernandezPiqueras, J
    Santos, J
    Perez de Castro, I
    Melendez, B
    Martinez, B
    Robledo, M
    Rivas, C
    Benitez, J
    CANCER GENETICS AND CYTOGENETICS, 1997, 98 (01) : 63 - 68
  • [25] MYD88 L265P mutation and CDKN2A loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas
    Nayyar, Naema
    White, Michael D.
    Gill, Corey M.
    Lastrapes, Matthew
    Bertalan, Mia
    Kaplan, Alexander
    D'Andrea, Megan R.
    Bihun, Ivanna
    Kaneb, Andrew
    Dietrich, Jorg
    Ferry, Judith A.
    Martinez-Lage, Maria
    Giobbie-Hurder, Anita
    Borger, Darrell R.
    Rodriguez, Fausto J.
    Frosch, Matthew P.
    Batchelor, Emily
    Hoang, Kaitlin
    Kuter, Benjamin
    Fortin, Sarah
    Holdhoff, Matthias
    Cahill, Daniel P.
    Carter, Scott
    Brastianos, Priscilla K.
    Batchelor, Tracy T.
    BLOOD ADVANCES, 2019, 3 (03) : 375 - 383
  • [26] CHROMOSOME 9P21 CDKN2A/CDKN2B GENE VARIATION EXPLAINS 12% OF INCIDENT CARDIOVASCULAR EVENTS IN THE POPULATION BUT DOES NOT ADD INCREMENTAL VALUE ON RISK PREDICTION BEYOND TRADITIONAL RISK FACTORS- THE MALMO DIET AND CANCER STUDY
    Gransbo, Klas
    Almgren, Peter
    Sjogren, Marketa
    Smith, Gustav
    Engstrom, Gunnar
    Hedblad, Bo
    Melander, Olle
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E1676 - E1676
  • [27] Aberrations of the p53 pathway components p53, MDM2 and CDKN2A appear independent in diffuse large B cell lymphoma
    MB Møller
    Y Ino
    A-M Gerdes
    K Skøjdt
    DN Louis
    NT Pedersen
    Leukemia, 1999, 13 : 453 - 459
  • [28] Aberrations of the p53 pathway components p53, MDM2 and CDKN2A appear independent in diffuse large B cell lymphoma
    Moller, MB
    Ino, Y
    Gerdes, AM
    Skjodt, K
    Louis, DN
    Pedersen, NT
    LEUKEMIA, 1999, 13 (03) : 453 - 459
  • [29] Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: a GELA study
    Jardin, Fabrice
    Jais, Jean-Philippe
    Molina, Thierry-Jo
    Parmentier, Francoise
    Picquenot, Jean-Michel
    Ruminy, Philippe
    Tilly, Herve
    Bastard, Christian
    Salles, Gilles-Andre
    Feugier, Pierre
    Thieblemont, Catherine
    Gisselbrecht, Christian
    de Reynies, Aurelien
    Coiffier, Bertrand
    Haioun, Corinne
    Leroy, Karen
    BLOOD, 2010, 116 (07) : 1092 - 1104
  • [30] Leukemic-Phase Diffuse Large B-Cell Lymphoma with t(14;18), CDKN2A and MLL Deletion Presenting with an Infiltrative Skin Rash
    Sheng, Iris Y.
    Treaba, Diana Olguta
    Bishop, Kenneth D.
    BLOOD, 2016, 128 (22)